Navigation Links
Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
Date:12/14/2007


Worldwide Rights for All Potential Uses, Excluding U.S. and Japan

No Other Existing Therapeutic Treatment for Celiac Disease

BASINGSTOKE, England and PHILADELPHIA, December 14 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announces that it has acquired the worldwide rights, excluding the U.S. and Japan, to AT-1001 from Alba Therapeutics Corporation (Alba). AT-1001 is Alba's lead inhibitor of barrier dysfunction in various gastrointestinal disorders that is currently in Phase 2 development for the treatment of Celiac disease. Shire has acquired rights to all uses for AT-1001, which may also be studied for the treatment of Crohn's disease and other indications.

Matthew Emmens, Chief Executive Officer, commented: "The licensing of AT-1001 from Alba is a natural fit to our growing portfolio of gastrointestinal products. This product will be marketed to specialist physicians and we would expect to use our existing European sales force that is currently establishing relationships and expertise in the GI area through the marketing of MEZAVANT XL."

Financial terms of the license are geared to the successful development and commercialization of the product. Shire will pay Alba an upfront license fee of $25 million and further development and sales-based milestones totalling to a maximum of $300.5M should the product reach blockbuster status. Shire will also pay royalties on net sales of the product, with tiered, single or double digit royalty rates.

Alba and Shire will form a joint development committee to monitor R&D activities of AT-1001. Alba will fund all development until AT-1001 has completed Proof of Concept, which is expected to be in the first half of 2009, after which Shire and Alba will share equally development costs under a joint development plan.

About Celiac disease:

Celiac disease is a T-cell mediated auto-immune dis
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. ATS Medical Expands Open Pivot Heart Valve Offerings
9. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
10. BioLife Solutions Expands Scientific Advisory Board
11. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)..., , Security personnel need to be able to find ...ontact with them. To aid such searches, the Nation...ith support from the Department of Homeland Securi...al, Standard Reference Material (SRM) 2905, Trace ...laboratory assay methods, the SRM will be helpful ...
(Date:11/18/2009)..., Scientists at Queen,s University Belfast are de... illegal drugs which will help in the fight agains... will use special gel pads to ,swipe, an individua...analysed by a scanning instrument that can detect ...l allow better, faster decisions to be made in res...
(Date:11/18/2009)..., , Vernier,s experience in data analys...rer (TM) program kits and curricula provid...ation ,, BEAVERTON, Ore., Nov. 18 /PRNewswire... of educational science interfaces, sensors, and s...ional manufacturer and distributor of life science...
(Date:11/18/2009)..., , EAST GRINSTEAD, West Sussex, U.K. and ... Systems, a Magellan Biosciences business and prem...ity products for microbiology labs, has expanded i...h and development facility to meet increasing glob...r susceptibility and identification testing. The e...
Breaking Biology Technology:New NIST trace explosives standard slated for homeland security duty 2New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
... Cell Product Candidate Enters Clinical Trials, R...ls, a,clinical-stage company developing novel anti...oday announced the successful completion of the fi...ng $93 million. This tranche,brings the total Seri...a,Phase4 Ventures participated in the financing al...
... Wall St. Network,s 3-Minute,Press Show is a dail...that,features in-depth interviews with public comp...ess releases., The show is designed to provide vi...nd its impact on the company,s growth., Shows ...et/3-min-press/3-min-press.php , The following ex...
... Rising concerns over food and water saf...sting contaminants thereby generating strong deman...Market size projections look bright with the 2012 ...he largest market for agricultural and environment...ents the largest and fastest growth segment. , ...
Other Biology Technology:OncoMed Pharmaceuticals Completes Series B Financing 2OncoMed Pharmaceuticals Completes Series B Financing 3[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO 2Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts 2Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts 3
(Date:11/20/2009)...group of University of Oklahoma researchers were s...e human genome project. Today, the OU Advanced C...international effort to sequence the tomato genome... Science Foundation for plant genomics. , "The ...mproving the tomato and crop yields will improve q...
(Date:11/20/2009)...n in the origin of biological molecules like RNA a... years ago from simple precursors. Now, in a study...y have reconstructed one of the earliest evolution...individual subunits using nothing but warm water. ...the first biological molecules present, before DNA...
(Date:11/20/2009)...ction of a single bacterial gene into yeast, resea...Netherlands achieved three improvements in bioetha...More ethanol, less acetate and elimination of the ... was published in the scientific journal Applied ..., Bioethanol is made by the yeast Saccharomyces ce...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Delft breakthrough in bioethanol production from agricultural waste 2Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 1Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 2Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 3Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 4How diarrheal bacteria cause some colon cancers revealed in mouse studies 55081 1How diarrheal bacteria cause some colon cancers revealed in mouse studies 55081 2How diarrheal bacteria cause some colon cancers revealed in mouse studies 55081 3Some skin cancer may be mediated by primary cilia activity 9670 1Some skin cancer may be mediated by primary cilia activity 9670 2Some skin cancer may be mediated by primary cilia activity 9670 3
...UC) suggests that the widely abused club drug "ecs...ine cells in the brain during fetal development. ...ion of voluntary movement, the findings, the resea...logical diseases like Parkinson,s. , Led by Jack...as presented today as an abstract at the Society f...
...species of green algae that practice different for...ight on one route by which evolution gave rise to ...and egg cells. The findings, which indicate that a...uction was likely co-opted during evolution to par...ported by Hisayoshi Nozaki and colleagues at the U...
... be triggered in the thymus, where the immune syst... just one of the body,s thousands of proteins as "...t autoimmunity can start in this cradle of the imm...mune diseases emerge, such as the pancreas in the ...id arthritis. , The discovery, from a mouse model...
Other Biology News:Research links 'ecstasy' to survival of key movement-related cells in brain 2A new male-specific gene in algae unveils an origin of male and female 2Autoimmune disease triggered if T cells miss a single protein early on 2Autoimmune disease triggered if T cells miss a single protein early on 3
Zymoclean Gel DNA Recovery Kit from Zymo Research
Rabbit Complement from Equitech-Bio
Stat-Pack Sputolysin Reagent from Caldon Biotech, Inc.
UltraClean 15 Kit from Mo Bio Laboratories, Inc.
Biology Products: